Why It Matters

Procter & Gamble is scaling back its internal lobbying operation even as the consumer goods giant continues aggressive efforts to influence Washington policy. The company's in-house team shrunk to six lobbyists in the first quarter of 2026, down from eight in the prior period, according to its quarterly filing.

The reduction comes as P&G grapples with mounting financial pressure from tariffs and trade policy. The company reported a $1 billion pretax hit from Trump-era tariffs and has implemented mid-single-digit price hikes on 25% of its U.S. products starting in August to offset tariff costs. China accounted for 23% of P&G's supplier shipments in the first quarter of 2026, leaving the company exposed to trade tensions.

P&G's tariff exposure is reshaping its business fundamentals. The company announced it would cut 7,000 jobs, approximately 15% of its nonmanufacturing workforce, over two years, explicitly linking the reductions to tariff pressures. More than 3,500 positions had been eliminated one year into the restructuring plan as of June 2026.

The company's CFO stated that tariffs and commodity costs created a headwind of approximately $0.25 per share, pushing earnings per share toward the lower end of guidance. P&G reported its worst sales growth in 7 years. Yet the company continues betting on policy intervention, maintaining a substantial lobbying footprint even while trimming its in-house team.

By the Numbers

P&G spent $661,000 on in-house lobbying in the second quarter of 2026, down slightly from $818,900 in the first quarter. Over the past four quarters, the company spent $5.7 million on total lobbying across its in-house operation and five external firms: Washington Tax and Public Policy Group LLC, Harbinger Strategies LLC, BGR Government Affairs LLC, and Ridgeline Advocacy Group LLC.

Broader Context

P&G's lobbying efforts span multiple policy domains. The company has focused heavily on tax policy, logging 39 lobbying contacts on taxation and Internal Revenue Code issues over the past five years. Manufacturing issues drew 29 contacts, while tariff bills generated 17 separate lobbying efforts.

Recent filings show P&G lobbying on FDA review of over-the-counter product ingredients, updates to the Toxic Substances Control Act, plastics recycling initiatives, and the Organisation for Economic Co-operation and Development (OECD) Digital Tax Project on global minimum tax implementation. The company also lobbied on U.S. Manufacturing Policy, as well as issues related to the US-Mexico-Canada Trade Agreement review.

The Bottom Line

P&G is consolidating its in-house lobbying operation while maintaining robust engagement across multiple policy fronts. The staffing reduction may reflect broader cost pressures, yet the company continues spending millions to shape trade, tax, and regulatory policy as it navigates tariff headwinds and restructuring challenges.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article